KIMS Shares Make Strong Debut Listing at a 22% Premium

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  
  • Home
  • Views On News
  • Jun 28, 2021 - KIMS Shares Make Strong Debut Listing at a 22% Premium

KIMS Shares Make Strong Debut Listing at a 22% Premium

Jun 28, 2021

Shares of Krishna Institute of Medical Sciences (KIMS) made a strong debut on the stock exchanges today.

Shares listed at Rs 1,008.90 on the BSE, a 22.29% premium over its issue price of Rs 825. On the NSE, the stock listed at Rs 1,009, up 22.30% from issue price.

Post listing, KIMS shares soared to Rs 1,059.

However, shares of the company pared some of its gains to end at Rs 996.

The company now commands a marketcap of Rs 79.7 bn.

KIMS IPO gets Ashish Kacholia interested

Renowned investor Ashish Kacholia had placed an application for over 2 m shares, worth about Rs 1.8 bn in the initial public offer (IPO) of KIMS Hospitals.

Ashish Kacholia is known for his bets on mid-cap and small-cap stocks.

Birlasoft, Mastek, Poly Medicure, Apollo Tricoat Tubes, Phillips Carbon, and Caplin Point are some of his top holdings.

The Rs 21.4 bn IPO was open for subscription between 16 June and 18 June. This included a little over Rs 9.6 bn, that was mobilised from anchor investors.

--- Advertisement ---
Act Now - Govt's Mega 2023 Plan Could Bring a Tsunami of Wealth

The Indian government is planning to cover 40,000 km of national highways with EV charging stations by 2023.

This could accelerate EV adoption in India and lead to a potential massive rally in a few EV stocks.

We've already identified 3 such EV stocks for you.

And we'll be revealing all details about them in an exclusive online event this coming Monday.

Click the link below to register immediately.

YES, Register Me for FREE.
------------------------------

The IPO saw strong response as the offer received bids for 55,655,046 shares compared with 14,413,073 shares on offer.

The quota reserved for qualified institutional buyers (QIBs) was subscribed 5.26 times while the one for non-institutional investors received 1.89 times bids.

Retail investors also showed strong participation as the quota reserved for them was subscribed to 2.89 times.

Grey market premium holds

Ahead of its listing, KIMS shares were trading at a premium of Rs 110 or at a price of Rs 935 in the grey market.

Shares were expected to list at premium to its issue price given the strong response seen from investors.

The strong listing can be attributed to a decent performance last week by Shyam Metalics and Sona Comstar.

Last week, Shyam Metalics listed at Rs 380, a 24.2% premium over its issue price of Rs 306.

Meanwhile, Sona BLW Precision Forgings listed at Rs 302.4, a 3.9% premium to issue price of Rs 291 per share. Later in the day, shares of the company were locked in the 20% upper circuit on the back of strong demand.

On top of all this, market sentiment also had a role to play. Benchmark indices BSE Sensex and NSE Nifty opened at record highs today before paring gains.

Indian share markets rose to record highs tracking the positive US stock markets and mixed Asian shares.

Market experts are suggesting KIMS shareholders to hold the stock, showing emphasis on the company's financials and the fact that HNI and mutual fund houses are expected to buy stake in the company from the secondary market.

Covid Impact

Despite a surge in topline and bottomline, KIMS said that the Covid-19 pandemic had an adverse impact on its operations.

In March 2020 and more so in April 2020, it witnessed a substantial decline in in-patient and out-patient volumes.

Find Out: How to Create Massive Gains from Govt's Mega 2023 Plan?

When compared to February 2020, its inpatient volumes fell by more than half in April 2020.

This was because some patients were reluctant to visit hospitals due to a perceived notion of increased risk of infection.

Further, the dependence of KIMS on hospitals in Hyderabad is also a concern.

The company also competes with strong peers such as Apollo Hospitals, Fortis Healthcare, and Aster DM Healthcare, among others.

About Krishna Institute of Medical Sciences

Incorporated in 1973, Krishna Institute of Medical Sciences (KIMS) is one of the largest healthcare groups in Andhra Pradesh and Telangana.

KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, and tertiary care in tier 2-3 cities.

--- Advertisement ---
Act Now - Govt's Mega 2023 Plan Could Bring a Tsunami of Wealth

The Indian government is planning to cover 40,000 km of national highways with EV charging stations by 2023.

This could accelerate EV adoption in India and lead to a potential massive rally in a few EV stocks.

We've already identified 3 such EV stocks for you.

And we'll be revealing all details about them in an exclusive online event this coming Monday.

Click the link below to register immediately.

YES, Register Me for FREE.
------------------------------

The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, and mother & child care.

As of 31 March 2021, it operates through 9 multi-specialty hospitals under the brand name of 'KIMS Hospitals' with an aggregate bed capacity of 3,064 including over 2,500 operational beds.

After the listing of KIMS shares at BSE and NSE, promoters' holding in the company now stands at 38.84%, which was at 46.81% before the issue listing.

It remains to be seen how the stock performs going forward.

For a sector overview, read our pharmaceuticals sector report.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...

Equitymaster requests your view! Post a comment on "KIMS Shares Make Strong Debut Listing at a 22% Premium". Click here!

  

More Views on News

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

A Complete Guide for Beginners on How to Invest in IPOs

As an investor, you must have endeavoured to find a suitable opportunity for investing in IPOs. But do you know what is an IP...

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KIMS SHARE PRICE


Oct 20, 2021 12:27 PM

TRACK KIMS

KIMS - MEDINOVA DIAG. COMPARISON

COMPARE KIMS WITH

MARKET STATS